Antidote Technologies' Series C Round

Antidote Technologies raised a round of funding on September 07, 2017.

Antidote, formerly TrialReach, a digital health company that aims to accelerate the breakthroughs of new treatments by bridging the gap between medical research and the people who need them. Antidote …

Articles about Antidote Technologies' Series C Round: